Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
PNT2002 / POINT Biopharma, Lantheus
Lutetium-177 PNT2002 for Prostate Cancer | Open Medscience
Anticipated Timelines PNT2002 (Prostate Cancer) PNT2003 (SSRT+ non-GEP ...
STRUCTUR 2 SC - Hellenic Dental Market
VOCO Structur 3 - kasetės 5 x 50 ml A2 | Medsauga.lt
ESMO 2024: Efficacy of 177Lu-PNT2002 in PSMA-Positive mCRPC Following ...
(R)-Zadavotide guraxetan ((R)-PSMA I&T) | PSMA Inhibitor | MedChemExpress
Frontiers | Initial clinical experience with [177Lu]Lu-PNT2002 ...
ESMO 22: Results of the 177Lu-PNT2002 SPLASH Trial | GU Oncology Now
Dose‐adapted stereotactic body radiation therapy based on the response ...
Chemical structures of 177 Lu-PSMA-617 and 177 Lu-PSMA I&T. | Download ...
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer ...
(Color online) Rolled structures of α-PNT and β-PNT seen from the axial ...
A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu ...
PSMA-Targeting Radioligand Therapy in Prostate Cancer | Published in ...
FDA Fast Tracks 177Lu-PNT2002 for the Treatment of mCRPC | Targeted ...
FDA Fast Tracks 177Lu-PNT2002 for the Treatment of mCRPC
Adding 177Lu-PNT2002 to SBRT Improves PFS in Oligorecurrent Prostate ...
More Than Meets the Eye: Scientific Rationale behind Molecular Imaging ...
177Lu-PNT2002 Received FDA Fast Track Designation for Metastatic CRPC
SPLASH: 177Lu-PNT2002 achieves phase 3 outcomes for mCRPC | Urology Times
SPLASH: 177Lu-PNT2002 achieves phase 3 outcomes for mCRPC
作为靶向前列腺特异性膜抗原的治疗性放射性药物的177Lu-DOTA-HYNIC-iPSMA的制作方法
Prostate Cancer Molecular Imaging and Therapy in MIRROR and 177Lu ...
177Lu–Prostate-specific Membrane Antigen Radioligand Therapy in ...
a a representation of the Pnt2258 molecule. the Pnt100 oligonucleotide ...
| (A) Geometrical structures for optimized neutral and cationic PNT ...
【速递】礼来收购PSMA核药变故？从市场竞争角度分析医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The P2/m structure of PN2, which becomes stable at pressures of above ...
Efficacy of 177Lu-PNT2002 in PSMA-Positive mCRPC Following Progression ...
POINT生物制药在PNT2002的3期SPLASH试验中完成随机化 - 中国核技术网
ESMO 2022: Efficacy and Safety of 177Lu-PNT2002 Prostate-Specific ...
177Lu-PNT2002 Meets Primary Endpoint in Phase III mCRPC Trial ...
AUA 2024: mCRPC: Key Updates in Radioligand Therapy, PSMA Sensitive Disease
LBA65 Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following ...
PNT
(PDF) Initial clinical experience with [Lu]Lu-PNT2002 radioligand ...
Electrophysiological effects and molecular modeling of PnTx2-5 and ...
Illustration of the synthesis of PNDIT2/IM‐f for transient electronics ...
New therapy delays progression of recurrent prostate cancer | UCLA Health
PNT 2 | PDF
ESMO 2024: Scientific Congress Highlights: Genitourinary Tumors, Prostate
SNOM acquisitions of dual labelled PNT2 cells. Images reveal the ...
Lilly Plans to Purchase POINT Biopharma, Enhancing Cancer Treatment ...
🚀 LUNAR phase II trial RCT of pts w/ oligorecurent hormone-sensitive # ...
核药赛道探险者：POINT Biopharma，扎根高端用药布局_摩熵医药(原药融云)
Estudio sobre el cáncer de próstata resistente a la castración ...
ESMO 2025: 177Lutetium-PSMA Therapy Neoadjuvant to Stereotactic ...
Alpha and Beta Radiation for Theragnostics - PET Clinics
AUA 2023: Third Update: What is the Urologists Role for Theranostics?
Структур 2 СЦ (Structur 2 SC) Voco
Structures – JCAF
Integrated PNT System (dark grey: standard, light grey: considered ...
Lantheus和POINT 生物制药宣布就PNT2002和PNT2003的商业化达成战略合作和独家许可协议 - 中国核技术网
ESMO 2024: Will Theranostics Become Standard of Care?
Internal structure of the PNT model. | Download Scientific Diagram
Primary Structure Of Protein Diagram
C6H6 lewis structure, molecular geometry, bond angle, hybridization
177Lu-PNT2002 Boosts rPFS in PSMA+ mCRPC Following ARPI Progression ...
177Lu-PNT2002 Significantly Improves rPFS Vs ARPI in Metastatic ...
POINT Biopharma Confirms No Disruptions to the Manufacturing and ...
核药行业报告：创新驱动的高壁垒领域，看好RDC未来发展 报告出品方： 招商证券 以下为报告原文节选------ 一、核药：高壁垒领域，看好 ...
Overview of PNT-Unit's Core. | Download Scientific Diagram
Sphingophospholipid Structure Diagram
ESMO 2024 Quick Take Insights: Prostate Cancer
SEM of PNT2 (a, b), nanotubes outer diameter distribution of PNT2 (c ...
ESMO 2024 Quick Take Insights: A Focus on SPLASH
